018922197

NOVATUS

---

September 5, 2023

Trademark Summary

The trademark NOVATUS was filed by Novatus Global Ltd, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on September 12, 2023, and received one opposition filed on December 4, 2023 by Starship Beteiligungsgesellschaft mbH on Likelihood of confusion. the opponent was represented by Eversheds Sutherland (Germany) Rechtsanwälte Steuerberater Solicitors Partnerschaft mbB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued December 4, 2023

The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on June 5, 2024. Change of name and professional address of the trademark registration was recorded on July 30, 2024.

---

Goods And Services

• The mark was filed in class 35 with following description of goods:
  
  1. Business risk management services
  2. Business risk assessment services
  3. Advisory services relating to business risk management
  4. Advisory services for business management
  5. Business consultancy
  6. Business administration consultancy
  7. Assistance, advisory services and consultancy with regard to business planning
  8. Assistance, advisory services and consultancy with regard to business management
  9. Assistance, advisory services and consultancy with regard to business organization
  10. Data management services
  11. Document preparation
  12. Statistical analysis and reporting services for business purposes
  13. All of the aforesaid services only directed to financial services firms and none of the aforesaid services relating to the development, production and offering of pharmaceuticals, medical or healthcare products, including services to obtain authorisation and approval for the marketing of such products.
• The mark was filed in class 36 with following description of goods:
  
  1. Advisory services relating to [financial] risk management
  2. Investment risk assessment services
  3. Financial risk management
  4. Financial advisory services
  5. Financial information
  6. Financial consultancy
  7. Financial research
  8. Preparation of financial reports and analysis
  9. Financial advisory and consultancy services
  10. Financial management
  11. Investment management
  12. All of the aforesaid services only directed to financial services firms and none of the aforesaid services relating to the development, production and offering of pharmaceuticals, medical or healthcare products, including services to obtain authorisation and approval for the marketing of such products.
• The mark was filed in class 42 with following description of goods:
  
  1. Development and testing of computing methods, algorithms and software
  2. Software development
  3. Computer software design services
  4. Computer programming
  5. Software as a service [SaaS]
  6. Providing temporary use of online non-downloadable software
  7. Hosting of databases
  8. All of the aforesaid services only directed to financial services firms and none of the aforesaid services relating to the development, production and offering of pharmaceuticals, medical or healthcare products, including services to obtain authorisation and approval for the marketing of such products.
• The mark was filed in class 45 with following description of goods:
  
  1. Reviewing standards and practices to assure compliance with laws and regulations
  2. Legal compliance auditing
  3. Preparation of regulations
  4. Advisory services relating to regulatory affairs
  5. Regulatory compliance auditing
  6. Legal services
  7. Legal consultation services
  8. Legal document preparation services
  9. Legal information services
  10. Legal research
  11. All of the aforesaid services only directed to financial services firms and none of the aforesaid services relating to the development, production and offering of pharmaceuticals, medical or healthcare products, including services to obtain authorisation and approval for the marketing of such products.